<?xml version="1.0" encoding="UTF-8"?>
<p id="par0165">SSHT has been used for infectious diseases for perhaps the last 1900 years, and its efficacy in infectious diseases has been scientifically established.
 <xref rid="bib0055" ref-type="bibr">11</xref>, 
 <xref rid="bib0060" ref-type="bibr">12</xref>, 
 <xref rid="bib0065" ref-type="bibr">13</xref>, 
 <xref rid="bib0070" ref-type="bibr">14</xref>, 
 <xref rid="bib0075" ref-type="bibr">15</xref>, 
 <xref rid="bib0080" ref-type="bibr">16</xref>, 
 <xref rid="bib0085" ref-type="bibr">17</xref>, 
 <xref rid="bib0090" ref-type="bibr">18</xref>, 
 <xref rid="bib0095" ref-type="bibr">19</xref>, 
 <xref rid="bib0100" ref-type="bibr">20</xref>, 
 <xref rid="bib0105" ref-type="bibr">21</xref> In particular, SSHT has been used in various viral diseases based on its antiviral effect and—if contraindications are dully considered—it can be regarded as a relatively safe medication given its long history of use. In addition, considering the indications of SSHT, and the scope of its previous usage, we think that SSHT could be prescribed for COVID-19 patients with persistent fever, respiratory symptoms such as cough or sputum, and liver injury caused by conventional therapies.
</p>
